Science & Enterprise subscription

Follow us on Twitter

  • Spark Therapeutics, a developer of gene therapies, is gaining access to a technology that programs DNA sequences li… https://t.co/WGboSsrf7U
    about 16 hours ago
  • New post on Science and Enterprise: Gene Therapy Company Exploring DNA Circuit Technology https://t.co/2YUM4DVZRK #Science #Business
    about 16 hours ago
  • A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects again… https://t.co/3JtSqD1Sa2
    about 20 hours ago
  • New post on Science and Enterprise: Vaccine Stops Lyme Bacteria in Preclinical Test https://t.co/7H0Lc90nRe #Science #Business
    about 20 hours ago
  • Stop the panic porn ... Coronavirus Variants Don’t Have to Be Scary. Still, Mask Up. https://t.co/d6aDu2Ucj6
    about 23 hours ago

Please share Science & Enterprise

Infographic – Covax Begins Vaccine Deliveries

Chart: Covax deliveries

Deliveries so far represent a small fraction of the allotments to those countries, with deliveries for other allotments not yet underway. . . . → Read More: Infographic – Covax Begins Vaccine Deliveries

Cell-Based Fish Company Gains $8.25M in Seed Funds

Bluu Bioscience founders

The start-up enterprise Bluu Biosciences is underway creating seafood products from fish stem cells, and raising $US 8.25 million in seed funds. . . . → Read More: Cell-Based Fish Company Gains $8.25M in Seed Funds

Test Vaccine Protects Against Wide Coronavirus Range

Two piglets

Researchers at two Virginia universities developed an experimental vaccine that in tests with pigs protects against SARS-CoV-2 and other coronaviruses. . . . → Read More: Test Vaccine Protects Against Wide Coronavirus Range

Biotech Manufacturer Gains $525M in New Funds

BaseCamp lab

A company providing specialized lab and manufacturing services for cell and gene therapy developers is raising $525 million in its third venture funding round. . . . → Read More: Biotech Manufacturer Gains $525M in New Funds

CEPI Funding SARS-CoV-2 Variant Vaccines

SARS-Cov-2 virus

CEPI, an international consortium, is funding development of vaccines to protect against SARS-CoV-2 mutations, starting with B.1.351 discovered in Brazil. . . . → Read More: CEPI Funding SARS-CoV-2 Variant Vaccines

Microbe Therapy Maker Expands, Adds Venture Funds

C. difficile in petri dish

A company providing manufacturing services for microbiome drug developers is expanding its facilities, with an infusion of new venture funds. . . . → Read More: Microbe Therapy Maker Expands, Adds Venture Funds

$100M Challenge Seeks Carbon Removal Technologies

Climate change skyline

An XPrize challenge competition, sponsored by Elon Musk, is seeking new technologies that remove large quantities of carbon dioxide from the atmosphere. . . . → Read More: $100M Challenge Seeks Carbon Removal Technologies

Biotech, UK Govt to Design Covid-19 Variant Vaccines

Vaccine vials

A biotechnology company and a U.K. government agency agreed to quickly develop and produce vaccines to protect against emerging Covid-19 viral mutations. . . . → Read More: Biotech, UK Govt to Design Covid-19 Variant Vaccines

U.S. Supports Home Smartphone Covid-19 Test

Ellume home Covid-19 test

The U.S. government is funding large-scale production of Covid-19 home test kits that send results to the user’s smartphone. . . . → Read More: U.S. Supports Home Smartphone Covid-19 Test

Investors Raise $1.85B for Biotech Start-Ups

Investing monitor

A venture capital company investing in life science and health care businesses raised $1.85 billion to finance biotechnology start-ups. . . . → Read More: Investors Raise $1.85B for Biotech Start-Ups